Vincent Wai-Sun Wong

Vincent Wai-Sun Wong

UNVERIFIED PROFILE

Are you Vincent Wai-Sun Wong?   Register this Author

Register author
Vincent Wai-Sun Wong

Vincent Wai-Sun Wong

Publications by authors named "Vincent Wai-Sun Wong"

Are you Vincent Wai-Sun Wong?   Register this Author

100Publications

2377Reads

50Profile Views

Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis.

Aliment Pharmacol Ther 2019 Nov 16;50(9):1037-1048. Epub 2019 Sep 16.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/apt.15499DOI Listing
November 2019

Application of transient elastography in nonalcoholic fatty liver disease.

Clin Mol Hepatol 2019 Nov 8. Epub 2019 Nov 8.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3350/cmh.2019.0001nDOI Listing
November 2019

Changing NAFLD Epidemiology in China.

Hepatology 2019 Oct;70(4):1095-1098

Department of Medicine and Therapeutics, the Chinese University of Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.30848DOI Listing
October 2019

A new bile acid treatment for non-alcoholic fatty liver disease.

Lancet Gastroenterol Hepatol 2019 Oct 22;4(10):747-749. Epub 2019 Jul 22.

Department of Medicine and Therapeutics and State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Shatin, Hong Kong Special Administrative Region, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2468-1253(19)30183-9DOI Listing
October 2019

Letter of Editor: Could variceal screening stratified by liver/spleen stiffness replace the role of endoscopy? - authors' reply.

Hepatology 2019 Oct 26. Epub 2019 Oct 26.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.31005DOI Listing
October 2019

Low Risk of Variceal Bleeding in Patients With Cirrhosis After Variceal Screening Stratified by Liver/Spleen Stiffness.

Hepatology 2019 Sep 15;70(3):971-981. Epub 2019 Mar 15.

Institute of Digestive Disease, The Chinese University of Hong Kong, Shatin, Hong Kong.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hep.30522
Publisher Site
http://dx.doi.org/10.1002/hep.30522DOI Listing
September 2019

Risk of hepatitis B surface antigen seroreversion after corticosteroid treatment in patients with previous hepatitis B virus exposure.

J Hepatol 2019 Sep 6. Epub 2019 Sep 6.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2019.08.023DOI Listing
September 2019

Tenofovir is Associated With Lower Risk of Hepatocellular Carcinoma Than Entecavir in Patients With Chronic HBV Infection in China.

Gastroenterology 2019 Sep 28. Epub 2019 Sep 28.

Institute of Digestive Disease; Department of Medicine and Therapeutics, The Chinese University of Hong Kong; Hong Kong SAR, China; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong; Hong Kong SAR, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2019.09.025DOI Listing
September 2019

Performance of Simple Fibrosis Scores in Nonobese Patients With Nonalcoholic Fatty Liver Disease.

Clin Gastroenterol Hepatol 2019 Sep 28. Epub 2019 Sep 28.

Centre d'Investigation de la Fibrose Hépatique, Bordeaux University Hospital, Pessac, France; INSERM U1053, Bordeaux University, Bordeaux, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2019.09.027DOI Listing
September 2019

Reply to Sun, et al.

Clin Infect Dis 2019 Aug 1. Epub 2019 Aug 1.

Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciz725DOI Listing
August 2019

Non-alcoholic fatty liver disease in Asia: How is it different from the West?

J Gastroenterol Hepatol 2019 08;34(8):1267-1268

Institute of Digestive Disease, The Chinese University of Hong Kong, Shatin, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgh.14813DOI Listing
August 2019

Suboptimal treatment of dyslipidemia in patients with nonalcoholic fatty liver disease.

J Gastroenterol Hepatol 2019 Jul 23. Epub 2019 Jul 23.

Department of Medicine, Singapore General Hospital, Singapore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgh.14794DOI Listing
July 2019

Emerging medical therapies for non-alcoholic fatty liver disease and for alcoholic hepatitis.

Transl Gastroenterol Hepatol 2019 19;4:53. Epub 2019 Jul 19.

Division of Gastroenterology and Hepatology, Avera Transplant Institute, University of South Dakota Sanford School of Medicine, Sioux Falls, SD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tgh.2019.06.06DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691078PMC
July 2019

Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.

Hepatology 2019 Jun;69(6):2672-2682

Department of Pediatrics, School of Medicine and Nutrition Health Sciences, Emory University, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.30251DOI Listing
June 2019

Reply to: "NAFLD and beneficial effects of lifestyle intervention: Defining the meat of the matter".

J Hepatol 2019 Jun 2;70(6):1304. Epub 2019 Mar 2.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2019.02.008DOI Listing
June 2019

Improvement in enhanced liver fibrosis score and liver stiffness measurement reflects lower risk of hepatocellular carcinoma.

Aliment Pharmacol Ther 2019 Jun 25;49(12):1509-1517. Epub 2019 Apr 25.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/apt.15269DOI Listing
June 2019

Towards finite oral antiviral treatment for chronic hepatitis B.

Lancet Gastroenterol Hepatol 2019 Apr 20;4(4):260-262. Epub 2019 Feb 20.

Institute of Digestive Disease, Department of Medicine and Therapeutics, and State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2468-1253(19)30045-7DOI Listing
April 2019

HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues.

J Hepatol 2019 Mar 25;70(3):361-370. Epub 2018 Oct 25.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2018.10.014DOI Listing
March 2019

Corrigendum to "Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B" [J Hepatol 69 (2018) 278-285].

J Hepatol 2019 Mar 8;70(3):581. Epub 2019 Jan 8.

Graduate Institute of Clinical Medical Science, China Medical University, Taichung, Taiwan; Division of Gastroenterology, Taichung Veterans General Hospital, Taichung, Taiwan; Faculty of Medicine and Graduate Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan; Department of Public Health, China Medical University, Taichung, Taiwan; National Institute of Cancer Research, National Health Research Institutes, Miaoli, Taiwan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2018.12.010DOI Listing
March 2019

Impact of dose and duration of corticosteroid on the risk of hepatitis flare in patients with chronic hepatitis B.

Liver Int 2019 02 25;39(2):271-279. Epub 2018 Sep 25.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.13953DOI Listing
February 2019

Magnitude of Nonalcoholic Fatty Liver Disease: Eastern Perspective.

J Clin Exp Hepatol 2019 Jul-Aug;9(4):491-496. Epub 2019 Feb 7.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jceh.2019.01.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728533PMC
February 2019

Repeating measurements by transient elastography in non-alcoholic fatty liver disease patients with high liver stiffness.

J Gastroenterol Hepatol 2019 Jan 27;34(1):241-248. Epub 2018 Jun 27.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgh.14311DOI Listing
January 2019

Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.

J Hepatol 2018 12 22;69(6):1349-1356. Epub 2018 Aug 22.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2018.08.011DOI Listing
December 2018

Liver Ultrasound Elastography: An Update to the World Federation for Ultrasound in Medicine and Biology Guidelines and Recommendations.

Ultrasound Med Biol 2018 12 9;44(12):2419-2440. Epub 2018 Sep 9.

Department of Radiology, Northeastern Ohio Medical University and Southwoods Imaging, Youngstown, Ohio, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ultrasmedbio.2018.07.008DOI Listing
December 2018

Letter: chronic kidney disease risk in patients with chronic hepatitis B-authors' reply.

Aliment Pharmacol Ther 2018 12;48(11-12):1324

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/apt.15031DOI Listing
December 2018

Current Prevention and Treatment Options for NAFLD.

Adv Exp Med Biol 2018;1061:149-157

Department of Medicine and Therapeutics and State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-981-10-8684-7_12DOI Listing
November 2018

Chronic kidney disease progression in patients with chronic hepatitis B on tenofovir, entecavir, or no treatment.

Aliment Pharmacol Ther 2018 11 20;48(9):984-992. Epub 2018 Aug 20.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/apt.14945DOI Listing
November 2018

On-Treatment Improvement of MELD Score Reduces Death and Hepatic Events in Patients With Hepatitis B-Related Cirrhosis.

Am J Gastroenterol 2018 11 12;113(11):1629-1638. Epub 2018 Oct 12.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China. Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China. State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41395-018-0247-9DOI Listing
November 2018

Can the same controlled attenuation parameter cut-offs be used for M and XL probes for diagnosing hepatic steatosis?

J Gastroenterol Hepatol 2018 Oct 7;33(10):1787-1794. Epub 2018 May 7.

Institute of Digestive Disease, The Chinese University of Hong Kong, Sha Tin, Hong Kong.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/jgh.14150
Publisher Site
http://dx.doi.org/10.1111/jgh.14150DOI Listing
October 2018

Normal on-treatment ALT during antiviral treatment is associated with a lower risk of hepatic events in patients with chronic hepatitis B.

J Hepatol 2018 Oct;69(4):793-802

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2018.05.009DOI Listing
October 2018

Is Modest Drinking Good for the Liver?

Clin Gastroenterol Hepatol 2018 09 27;16(9):1404-1406. Epub 2018 Mar 27.

Department of Medicine and Therapeutics, Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2018.03.026DOI Listing
September 2018

Chronic Hepatitis B Increases Liver-Related Mortality of Patients With Acute Hepatitis E: A Territorywide Cohort Study From 2000 to 2016.

Clin Infect Dis 2018 09;67(8):1278-1284

Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciy234DOI Listing
September 2018

Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B.

J Hepatol 2018 08 16;69(2):278-285. Epub 2018 Mar 16.

Graduate Institute of Clinical Medical Science, China Medical University, Taichung, Taiwan; Division of Gastroenterology, Taichung Veterans General Hospital, Taichung, Taiwan; Faculty of Medicine and Graduate Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan; Department of Public Health, China Medical University, Taichung, Taiwan; National Institute of Cancer Research, National Health Research Institutes, Miaoli, Taiwan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2018.02.032DOI Listing
August 2018

Systematic review with meta-analysis: Change in liver stiffness during anti-viral therapy in patients with hepatitis B.

Dig Liver Dis 2018 08 15;50(8):787-794. Epub 2018 May 15.

Division of Gastroenterology, University of California San Diego, La Jolla, CA, United States; Division of Biomedical Informatics, University of California San Diego, La Jolla, CA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2018.05.005DOI Listing
August 2018

Noninvasive biomarkers in NAFLD and NASH - current progress and future promise.

Nat Rev Gastroenterol Hepatol 2018 08;15(8):461-478

University of Buenos Aires, Institute of Medical Research A Lanari, Buenos Aires, Argentina.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41575-018-0014-9
Publisher Site
http://dx.doi.org/10.1038/s41575-018-0014-9DOI Listing
August 2018

Effects of Diabetes and Glycemic Control on Risk of Hepatocellular Carcinoma After Seroclearance of Hepatitis B Surface Antigen.

Clin Gastroenterol Hepatol 2018 05 12;16(5):765-773.e2. Epub 2017 Dec 12.

Institute of Digestive Disease, Chinese University of Hong Kong, Hong Kong, China; Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong, China; State Key Laboratory of Digestive Disease, Chinese University of Hong Kong, Hong Kong, China. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15423565173145
Publisher Site
http://dx.doi.org/10.1016/j.cgh.2017.12.009DOI Listing
May 2018

Impact of diabetes mellitus and hepatitis B virus coinfection on patients with chronic hepatitis C: A territory-wide cohort study.

J Gastroenterol Hepatol 2018 Apr 26;33(4):934-941. Epub 2018 Jan 26.

Institute of Digestive Disease, The Chinese University of Hong Kong, Shatin, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgh.14003DOI Listing
April 2018

Invasive and non-invasive assessment of portal hypertension.

Hepatol Int 2018 Feb 30;12(Suppl 1):44-55. Epub 2017 Mar 30.

Department of Medicine and Therapeutics, 9/F, Clinical Sciences Building, Prince of Wales Hospital, 30-32 Ngan Shing Street, Shatin, Hong Kong, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12072-017-9795-0DOI Listing
February 2018

Prognostic Value of Controlled Attenuation Parameter by Transient Elastography.

Am J Gastroenterol 2017 Dec 31;112(12):1812-1823. Epub 2017 Oct 31.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong,China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ajg.2017.389DOI Listing
December 2017

Impact of age and gender on risk of hepatocellular carcinoma after hepatitis B surface antigen seroclearance.

J Hepatol 2017 11 24;67(5):902-908. Epub 2017 Jun 24.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2017.06.019DOI Listing
November 2017

New trends on obesity and NAFLD in Asia.

J Hepatol 2017 10 19;67(4):862-873. Epub 2017 Jun 19.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2017.06.003DOI Listing
October 2017

Advanced liver fibrosis but not steatosis is independently associated with albuminuria in Chinese patients with type 2 diabetes.

J Hepatol 2017 Oct 6. Epub 2017 Oct 6.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2017.09.020DOI Listing
October 2017

Durability of hepatitis B surface antigen seroclearance in untreated and nucleos(t)ide analogue-treated patients.

J Hepatol 2017 Oct 6. Epub 2017 Oct 6.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01688278173233
Publisher Site
http://dx.doi.org/10.1016/j.jhep.2017.09.018DOI Listing
October 2017

Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter.

J Hepatol 2017 09 12;67(3):577-584. Epub 2017 May 12.

Centre d'Investigation de la Fibrose Hépatique, Hôpital Haut-Lévêque, Bordeaux University Hospital, Pessac, France; INSERM U1053, Bordeaux University, Bordeaux, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2017.05.005DOI Listing
September 2017

Reply to: "Risk factors of hepatocellular carcinoma after hepatitis B surface antigen seroclearance".

J Hepatol 2017 Sep 19. Epub 2017 Sep 19.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2017.08.026DOI Listing
September 2017

How to identify patients with advanced liver disease in the community?

Hepatology 2017 07 27;66(1):7-9. Epub 2017 May 27.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.29197DOI Listing
July 2017

HCV Genotype 6 Increased the Risk for Hepatocellular Carcinoma Among Asian Patients With Liver Cirrhosis.

Am J Gastroenterol 2017 Jul 25;112(7):1111-1119. Epub 2017 Apr 25.

Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ajg.2017.123DOI Listing
July 2017

Mechanism and prediction of HCC development in HBV infection.

Best Pract Res Clin Gastroenterol 2017 Jun 5;31(3):291-298. Epub 2017 May 5.

State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bpg.2017.04.011DOI Listing
June 2017

The role of quantitative hepatitis B surface antigen revisited.

J Hepatol 2017 02 27;66(2):398-411. Epub 2016 Aug 27.

Department of Medicine and Therapeutics, Institute of Digestive Disease and State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2016.08.009DOI Listing
February 2017

Serum biomarkers for nonalcoholic fatty liver disease: Are we there yet?

Hepatology 2017 01 5;65(1):8-11. Epub 2016 Nov 5.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.28840DOI Listing
January 2017

Eliminating hepatitis B virus as a global health threat.

Lancet Infect Dis 2016 12 13;16(12):1313-1314. Epub 2016 Sep 13.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong Special Administrative Region, China; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Shatin, Hong Kong Special Administrative Region, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1473-3099(16)30214-6DOI Listing
December 2016

Reply.

Hepatology 2016 11 17;64(5):1820-1821. Epub 2016 May 17.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.28595DOI Listing
November 2016

Metabolic syndrome increases cardiovascular events but not hepatic events and death in patients with chronic hepatitis B.

Hepatology 2016 11 1;64(5):1507-1517. Epub 2016 Oct 1.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.28778DOI Listing
November 2016

Oxidized low-density lipoprotein in non-alcoholic steatohepatitis.

J Gastroenterol Hepatol 2016 Sep;31(9):1516-8

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Sha Tin, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgh.13381DOI Listing
September 2016

Pathogenesis and novel treatment options for non-alcoholic steatohepatitis.

Lancet Gastroenterol Hepatol 2016 09 10;1(1):56-67. Epub 2016 Aug 10.

Liver Research Group, Australian National University Medical School at The Canberra Hospital, Woden, ACT, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2468-1253(16)30011-5DOI Listing
September 2016

Reply.

Hepatology 2016 08 18;64(2):685-6. Epub 2015 Dec 18.

Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.28305DOI Listing
August 2016

In search of new biomarkers for nonalcoholic fatty liver disease.

Clin Liver Dis (Hoboken) 2016 Jul 26;8(1):19-23. Epub 2016 Jul 26.

Department of Medicine and Therapeutics and State Key Laboratory of Digestive Disease The Chinese University of Hong Kong Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cld.563DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6490188PMC
July 2016

Not routine screening, but vigilance for chronic liver disease in patients with type 2 diabetes.

J Hepatol 2016 06 26;64(6):1211-3. Epub 2016 Feb 26.

Indiana University School of Medicine, Indianapolis, IN, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2016.02.032DOI Listing
June 2016

Virus and Host Testing to Manage Chronic Hepatitis B.

Clin Infect Dis 2016 06;62 Suppl 4:S298-305

Department of Medicine and Therapeutics Institute of Digestive Disease State Key Laboratory of Digestive Disease, Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciw024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4889896PMC
June 2016

Utility and Safety of Tolvaptan in Cirrhotic Patients with Hyponatremia: a Prospective Cohort Study.

Ann Hepatol 2017 Jan - Feb;16(1):123-132

State Key Laboratory of Digestive Disease; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5604/16652681.1226823DOI Listing
May 2016

A LEAN treatment for non-alcoholic steatohepatitis.

Lancet 2016 Feb 20;387(10019):628-30. Epub 2015 Nov 20.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(15)00982-4DOI Listing
February 2016